| Innate or adaptive immunity? The example of natural killer cells E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ... science 331 (6013), 44-49, 2011 | 3136 | 2011 |
| CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones FA Harding, JG McArthur, JA Gross, DH Raulet, JP Allison Nature 356 (6370), 607-609, 1992 | 2199 | 1992 |
| Roles of the NKG2D immunoreceptor and its ligands DH Raulet Nature Reviews Immunology 3 (10), 781-790, 2003 | 1712 | 2003 |
| The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor S Gasser, S Orsulic, EJ Brown, DH Raulet Nature 436 (7054), 1186-1190, 2005 | 1568 | 2005 |
| Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity A Diefenbach, ER Jensen, AM Jamieson, DH Raulet Nature 413 (6852), 165-171, 2001 | 1369 | 2001 |
| β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells M Zijlstra, M Bix, NE Simister, JM Loring, DH Raulet, R Jaenisch Nature 344 (6268), 742-746, 1990 | 1300 | 1990 |
| Developmental potential and dynamic behavior of hematopoietic stem cells IR Lemischka, DH Raulet, RC Mulligan Cell 45 (6), 917-927, 1986 | 1113 | 1986 |
| Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages A Diefenbach, AM Jamieson, SD Liu, N Shastri, DH Raulet Nature immunology 1 (2), 119-126, 2000 | 1110 | 2000 |
| Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease B Meresse, Z Chen, C Ciszewski, M Tretiakova, G Bhagat, TN Krausz, ... Immunity 21 (3), 357-366, 2004 | 1010 | 2004 |
| NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy N Guerra, YX Tan, NT Joncker, A Choy, F Gallardo, N Xiong, S Knoblaugh, ... Immunity 28 (4), 571-580, 2008 | 1004 | 2008 |
| Regulation of ligands for the NKG2D activating receptor DH Raulet, S Gasser, BG Gowen, W Deng, H Jung Annual review of immunology 31, 413-441, 2013 | 898 | 2013 |
| The role of the NKG2D immunoreceptor in immune cell activation and natural killing AM Jamieson, A Diefenbach, CW McMahon, N Xiong, JR Carlyle, ... Immunity 17 (1), 19-29, 2002 | 840 | 2002 |
| Self-tolerance of natural killer cells DH Raulet, RE Vance Nature Reviews Immunology 6 (7), 520-531, 2006 | 795 | 2006 |
| A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules NC Fernandez, E Treiner, RE Vance, AM Jamieson, S Lemieux, ... Blood 105 (11), 4416-4423, 2005 | 727 | 2005 |
| Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus A Marshak-Rothstein, P Fink, T Gridley, DH Raulet, MJ Bevan, ML Gefter The Journal of Immunology 122 (6), 2491-2497, 1979 | 727 | 1979 |
| Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade J Hsu, JJ Hodgins, M Marathe, CJ Nicolai, MC Bourgeois-Daigneault, ... The Journal of clinical investigation 128 (10), 4654-4668, 2018 | 695 | 2018 |
| Regulation of the natural killer cell receptor repertoire DH Raulet, RE Vance, CW McMahon Annual review of immunology 19 (1), 291-330, 2001 | 681 | 2001 |
| Developmental regulation of T-cell receptor gene expression DH Raulet, RD Garman, H Saito, S Tonegawa Nature 314 (6006), 103-107, 1985 | 649 | 1985 |
| The structure, function, and molecular genetics of the gamma/delta T cell receptor DH Raulet Annual review of immunology 7 (1), 175-207, 1989 | 644 | 1989 |
| Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b RE Vance, JR Kraft, JD Altman, PE Jensen, DH Raulet The Journal of experimental medicine 188 (10), 1841-1848, 1998 | 605 | 1998 |
